1. Clinical implications of variable relative biological effectiveness in proton therapy for prostate cancer
- Author
-
A Carabe-Fernandez and A. Bertolet
- Subjects
Oncology ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Internal medicine ,medicine ,Relative biological effectiveness ,Proton Therapy ,Humans ,Radiology, Nuclear Medicine and imaging ,Linear Energy Transfer ,Proton therapy ,business.industry ,Radiotherapy Planning, Computer-Assisted ,Prostatic Neoplasms ,Hematology ,General Medicine ,medicine.disease ,Radiation therapy ,Variable versus ,030220 oncology & carcinogenesis ,business ,Relative Biological Effectiveness - Abstract
To study the potential consequences of differences in the evaluation of variable versus uniform relative biological effectiveness calculations in proton radiotherapy for prostate cancer.Experimental data with proton beams suggest that relative biological effectiveness increases with linear energy transfer. This relation also depends on thePhenomenological models clearly predict higher relative biological effectiveness values compared to microdosimetric kinetic model, that seems to approach to the constant value of 1.1 adopted in the clinics, at least for low linear energy transfer values achieved in typical prostate proton plans. All models predict a higher increase of the relative biological effectiveness-weighted dose for the prostate tumor than for the rest of structures involved due to its lower
- Published
- 2020